Q1 2026 Holdings
Filed 2026-05-15 | 114 holdings | $5.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $488.8M | 15,518,492 | 9.7% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $312.0M | 7,959,538 | 6.2% |
| Mdxhealth SA(MDXH)Call | SHS NEW | B5950S113 | $285.9M | 124,306,000 | 5.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $217.8M | 236,800 | 4.3% |
| Sinovac Biotech LTD(SVA) | SHS | P8696W104 | $184.5M | 2,718,735 | 3.7% |
| Avita Medical Inc(RCEL)Call | COM | 05380C102 | $154.4M | 40,966,100 | 3.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $149.5M | 2,382,100 | 3.0% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $141.5M | 3,530,702 | 2.8% |
| Astrazeneca PLC(AZN) | ORD | G0593M107 | $132.2M | 670,200 | 2.6% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $122.9M | $125,000,000 | 2.4% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $108.6M | 3,637,887 | 2.2% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $104.8M | 7,165,006 | 2.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $100.0M | 136,900 | 2.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $98.5M | 1,230,600 | 2.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $96.2M | 208,700 | 1.9% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $80.5M | 15,219,994 | 1.6% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $79.8M | 663,400 | 1.6% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $71.1M | 1,475,403 | 1.4% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $69.8M | 3,027,328 | 1.4% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $68.3M | 1,067,550 | 1.4% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $66.6M | 8,288,510 | 1.3% |
| CG Oncology Inc(CGON) | COM | 156944100 | $64.2M | 948,267 | 1.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $61.6M | 1,059,971 | 1.2% |
| Stryker Corporation(SYK) | COM | 863667101 | $60.0M | 182,500 | 1.2% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $56.1M | 925,000 | 1.1% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $55.6M | 2,052,900 | 1.1% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $55.6M | 172,500 | 1.1% |
| Pfizer Inc(PFE) | COM | 717081103 | $54.7M | 1,946,500 | 1.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $52.9M | 2,917,884 | 1.0% |
| Natera Inc(NTRA) | COM | 632307104 | $52.4M | 262,000 | 1.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $51.9M | 465,700 | 1.0% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $51.2M | 5,693,589 | 1.0% |
| Danaher Corp del(DHR) | COM | 235851102 | $50.4M | 265,800 | 1.0% |
| Caris Life Sciences Inc(CAI) | COM | 142152107 | $50.2M | 2,806,811 | 1.0% |
| Avita Medical Inc(RCEL) | COM | 05380C102 | $42.5M | $41,044,895 | 0.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $41.6M | 181,977 | 0.8% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $40.5M | 6,306,127 | 0.8% |
| Guardant Health Inc(GH) | COM | 40131M109 | $40.2M | 435,200 | 0.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $39.4M | 119,000 | 0.8% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $37.3M | 10,909,256 | 0.7% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $36.3M | 999,000 | 0.7% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $36.2M | 213,921 | 0.7% |
| Uniqure NV(QURE) | SHS | N90064101 | $34.9M | 2,136,149 | 0.7% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $34.1M | 2,693,929 | 0.7% |
| Elevance Health Inc Formerly(ELV) | COM | 036752103 | $33.6M | 114,700 | 0.7% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $32.8M | 4,715,864 | 0.7% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $31.0M | 1,196,955 | 0.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $29.3M | 2,454,400 | 0.6% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $29.0M | 10,570,300 | 0.6% |
| Neuropace Inc(NPCE) | COM | 641288105 | $27.6M | 2,096,527 | 0.5% |